Clinical Trials Logo

Glaucoma clinical trials

View clinical trials related to Glaucoma.

Filter by:

NCT ID: NCT04619654 Completed - Cataract Clinical Trials

Visual Outcomes With a Trifocal IOL in Subjects With Open-angle Glaucoma

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

This study will examine the visual outcomes of subjects undergoing cataract surgery and minimally invasive glaucoma surgery with the implantation of a trifocal intraocular lens.

NCT ID: NCT04610008 Completed - Glaucoma Clinical Trials

Optic Nerve Head Shape as a Predictor of the Formation of Acquired Pits of the Optic Nerve (APONs)

Start date: December 1, 2020
Phase:
Study type: Observational

Acquired pits of the optic nerve (APONs) are an area of focal loss of neural tissue associated with a discrete area of depression/excavation within the optic cup at the level of the lamina cribrosa. It is commonly associated with glaucoma and can be seen on the optic disc when examining the back of a patient's eye. It causes a characteristic visual field defect in the central 5-10 degrees of vision which has a significant impact of a patient's daily activities. There is no treatment to restore vision once it has formed. Previous studies suggest mechanical stress across this part of the eye may have role in the formation of APONs. The investigators therefore hypothesise that if a patient has a more elliptical shaped optic disc, which would have more irregular mechanical stress across it, it may have a higher risk of an APON forming. Patients with glaucoma attending the ophthalmology department at University Hospital of Wales have regular photographs taken of the optic nerve/optic disc as part of their routine clinical care in order to monitor the condition. The research team, who are all practicing ophthalmologists in the department, will review anonymised photographs to find optic discs with APONs, and another group with glaucoma but no APONs to use as a control. The research team will then measure the dimensions of the optic disc to determine if APONs are more common in optic discs with a more elliptical shape. The patients' clinical notes will then need to be accessed to collect data on the age, sex and diagnosis. This data will be anonymised using ID numbers once collected. The final outcomes of the study will the average measured dimensions of the optic disc in each group, and the position that the APON occurs.

NCT ID: NCT04552964 Completed - Glaucoma Clinical Trials

Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma

CONDORE
Start date: September 25, 2020
Phase: N/A
Study type: Interventional

Glaucoma is one of the most common chronic pathologies and affects several millions patients. Among these, many have a poorly controlled glaucoma, damaging vision and leading to blindness. One between principal reasons for poor glaucoma medication adherence is forgetfulness. To improve this issue, digital tools may benefit both ophthalmologists and patients by monitoring eye drop administration.

NCT ID: NCT04552314 Completed - Glaucoma Clinical Trials

Bleb Vascularity and the Outcomes After Trabeculectomy

Start date: July 2014
Phase:
Study type: Observational

1. Study objective: To evaluate the relationship between filtering bleb vascularity and the surgical outcomes after trabeculectomy 2. Study design: A prospective study of 51 eyes of 44 patients after primary MMC-augmented trabeculectomy. The follow-up was 12 months.

NCT ID: NCT04547036 Completed - Glaucoma Clinical Trials

Changes in Corneal Endothelial Cell Density After Transscleral ab Interno Glaucoma Gel Stent Implantation

Start date: January 30, 2020
Phase:
Study type: Observational

The objective of this study is to evaluate the change of endothelial cell count after XEN45 in patients with or without cataract operation.

NCT ID: NCT04536129 Completed - Glaucoma Clinical Trials

Effects of Topical Low Dose Preservative-free Hydrocortisone on Intraocular Pressure

Start date: November 4, 2019
Phase: N/A
Study type: Interventional

Evaluation of the safety and efficacy of hydrocortisone eye drops in the treatment of OSD (ocular surface disease) patients with and without glaucoma.

NCT ID: NCT04515030 Completed - Primary Glaucoma Clinical Trials

Changes of Trace Elements in Aqueous Humor, Blood and Tears and Analysis of Related Factors

Start date: August 20, 2020
Phase:
Study type: Observational

Trace elements are one of the indispensable substances in human body and play an important physiological role. Zinc is a trace element second only to iron in organisms, which is widely distributed in various systems and organs and plays an important biological role, and interacts with other trace elements such as copper and iron. With the improvement of detection methods, it is possible to detect the concentration of zinc and other trace elements in liquid samples. It is reported in the existing literature that there are significant changes in the concentration of trace elements in a variety of eye diseases. Our group intends to collect three kinds of samples (aqueous humor, blood and tears) of patients with primary glaucoma and age-related cataract who were treated in Sun Yat-sen Eye Center of Sun Yat-sen University from March 2020 to March 2021. Normal people with matched age and sex were recruited as normal control group (normal control group only collected blood and tear samples). Three methods (FI-ICP-MS, metabonomics and genomics) were used to study the concentration changes of patients with primary glaucoma in three kinds of body fluid samples, and the related factors were analyzed combined with clinical data, so as to provide a theoretical basis for studying the pathogenic mechanism and new prevention pathway of primary glaucoma.

NCT ID: NCT04508881 Completed - Glaucoma Clinical Trials

Intraluminal Stenting Versus External Ligation of Ahmed Glaucoma Valve

Start date: September 12, 2018
Phase: N/A
Study type: Interventional

Objectives: To compare the intraluminal stenting and external ligation of Ahmed Glaucoma Valve (AGV) regarding refractory glaucoma management and postoperative hypotony prevention. Patients and Methods: This randomized clinical trial included 30 eyes of 25 patients (age range: 44-56 y) with refractory glaucoma. This study was conducted during the period from September 2018 to January 2020. The study included two groups, AGV with intraluminal stenting group (n=15) and AGV with external ligation group (n=15). Follow up continued to a year post operation. The primary outcome was Intraocular pressure (IOP) and its association with the number of postoperative glaucoma medications. IOP ≤ 21 mmHg without medications announced complete success while IOP ≤ 21 mmHg with medications indicated qualified success. IOP of <6 mmHg defined hypotony. Key Words: Stenting- ligation- Ahmed valve- Hypotony

NCT ID: NCT04503590 Completed - Glaucoma Clinical Trials

Minimally Invasive Micro Sclerostomy: Performance and Safety Evaluation Study

Start date: May 29, 2019
Phase: N/A
Study type: Interventional

Eligible Glaucoma patients will undergo pre-surgery examination including: medicines list, blood tests and ECG. On surgery day: intraocular pressure (IOP) will be measured. Then a sub-conjunctival injection of Mitomycin C will be administered . The Minimally Invasive Micro Sclerostomy (MIMS) procedure is designed to create a drainage channel at the sclera-corneal junction by penetrating through the wall [scleral tissue] . MIMS procedure may be combined with cataract surgery. Patients will be followed up to 52 weeks post operation.

NCT ID: NCT04486976 Completed - Cataract Clinical Trials

Comparative Study of the Cornea/Anterior Segment OCT CASIA2 and the RTVue XR OCT Avanti With AngioVue Software

Start date: June 27, 2020
Phase: N/A
Study type: Interventional

This study is a prospective comparative, randomized, single center study to gather agreement and precision data in all subjects.